Metraipolis › archive › dc_72232fa6d5b2

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group… — Europe PMC PMID:42346265

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346265
DOI
10.3390/curroncol33060365
License (as archived)
solo-consultazione
Archived
2026-10-19T08:51:16.913Z
SHA-256 of the archived text
2c3333aecda005a4be2db8b4644d38f0e0325fdac10888cee2d10729afaea688
Stable URL of this page
https://metraipolis.com/documento/dc_72232fa6d5b2

How to cite

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group… — Europe PMC PMID:42346265 — Europe PMC (en), https://europepmc.org/article/MED/42346265 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72232fa6d5b2 (Metraipolis archive dc_72232fa6d5b2, sha256 2c3333aecda005a4be2db8b4644d38f0e0325fdac10888cee2d10729afaea688)
BibTeX
@misc{dc72232fa6d5b2,
  title = {Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group… — Europe PMC PMID:42346265},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346265},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72232fa6d5b2; sha256 2c3333aecda005a4be2db8b4644d38f0e0325fdac10888cee2d10729afaea688},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346265. Agents can read the archived copy with the MCP tool read_document.